Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

997
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
997
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression01:05

Long-term Depression

33.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.7K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rapamycin Pharmacogenomic Approach for the Childhood Dementia Niemann-Pick C.

Journal of inherited metabolic disease·2026
Same author

Arylsulfatase L is a Golgi chondroitin sulfatase regulating skeletal development.

The Journal of biological chemistry·2026
Same author

Crosstalk between inflammation and autophagy in CeD organoids.

Scientific reports·2026
Same author

Arylsulfatase I is a novel lysosomal chondroitin endosulfatase regulating endochondral ossification.

Matrix biology : journal of the International Society for Matrix Biology·2026
Same author

Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease.

Disease models & mechanisms·2026
Same author

Author Correction: Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.

Nature cell biology·2026

Related Experiment Video

Updated: Mar 22, 2026

Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.9K

Brain Disorders Due to Lysosomal Dysfunction.

Alessandro Fraldi1, Andrés D Klein1, Diego L Medina1

  • 1Telethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.

Annual Review of Neuroscience
|April 20, 2016
PubMed
Summary
This summary is machine-generated.

Lysosomes are key to brain health, regulating cell signaling and gene expression. Targeting lysosomal pathways, like transcription factor EB (TFEB), may offer new treatments for neurodegenerative diseases.

Keywords:
TFEBautophagylysosomal storage disorderslysosomeneurodegenerative diseasestranscription factor EBα-synuclein

More Related Videos

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
07:43

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

Published on: May 12, 2015

11.9K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

5.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.9K
Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
07:43

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

Published on: May 12, 2015

11.9K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

5.0K

Area of Science:

  • Cellular Biology
  • Neuroscience
  • Molecular Biology

Background:

  • Lysosomes were traditionally viewed as simple degradative organelles.
  • Recent research reveals lysosomes' roles in signal transduction (mTORC1) and gene expression (TFEB).
  • Dysfunctional autophagy and lysosomal pathways are linked to neurodegenerative diseases and lysosomal storage disorders.

Purpose of the Study:

  • To review the cellular biology of lysosomes.
  • To explore mechanisms linking lysosomal dysfunction to neurodegeneration.
  • To discuss therapeutic strategies targeting TFEB and lysosomes for neurological conditions.

Main Methods:

  • Literature review of autophagic and lysosomal pathways.
  • Analysis of molecular mechanisms in neurodegeneration.
  • Discussion of therapeutic targets in neurological disorders.

Main Results:

  • Lysosomes actively influence cellular signaling and gene regulation.
  • Impaired lysosomal function is a significant factor in neurodegenerative disease pathogenesis.
  • Targeting TFEB and lysosomal pathways shows therapeutic potential.

Conclusions:

  • Lysosomes are crucial for maintaining brain homeostasis.
  • Understanding lysosome-neurodegeneration links can drive novel therapeutic development.
  • Targeting TFEB and lysosomes offers promising avenues for treating neurological diseases.